WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|7|787-797

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.7, 2009-09, pp. : 787-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval

By Saitoh Anri  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 219-230

Humana Press, Inc

Access to resources Recommend Favorite

WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone

By Nakajima Hiroko   Kawasaki Kotomi   Oka Yoshihiro   Tsuboi Akihiro   Kawakami Manabu   Ikegame Kazuhiro   Hoshida Yoshihiko   Fujiki Fumihiro   Nakano Akiko   Masuda Tomoki   Wu Fei   Taniguchi Yuki   Yoshihara Satoshi   Elisseeva Olga   Oji Yusuke   Ogawa Hiroyasu   Azuma Ichiro   Kawase Ichiro   Aozasa Katsuyuki   Sugiyama Haruo  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 617-624

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

By Romero Pedro   Cerottini Jean-Charles   Speiser Daniel  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite

Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine

By Couty Jean-Pierre   Crain Anne-Marie   Gerbaud Sylvie   Labasque Marilyne   Marchiol Carmen   Fradelizi Didier   Boudaly Sarah   Guettier Catherine   Vignuzzi Marco   Werf Sylvie   Escriou Nicolas   Viguier Mireille  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 8, 2008-08 ,pp. : 1161-1171

Springer Publishing Company

Access to resources Recommend Favorite

Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes

By Neumann Frank   Wagner Claudia   Kubuschok Boris   Stevanovic Stefan   Rammensee Hans-Georg   Pfreundschuh Michael  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 589-599

Springer Publishing Company

Access to resources Recommend Favorite